Your browser doesn't support javascript.
loading
Evaluation of the impact of human immunodeficiency virus pre-exposure prophylaxis on new human immunodeficiency virus diagnoses during the COVID-19 pandemic.
Keane, A; Regan, S O; Quinn, L; Murphy, D; Kelly, B O; Lynam, A; Lyons, F; Devitt, E.
Afiliación
  • Keane A; Department of Genitourinary Medicine and Infectious Diseases, 58024GUIDE Clinic, St James Hospital, Dublin, Ireland.
  • Regan SO; Department of Genitourinary Medicine and Infectious Diseases, 58024GUIDE Clinic, St James Hospital, Dublin, Ireland.
  • Quinn L; Department of Genitourinary Medicine and Infectious Diseases, 58024GUIDE Clinic, St James Hospital, Dublin, Ireland.
  • Murphy D; Department of Genitourinary Medicine and Infectious Diseases, 58024GUIDE Clinic, St James Hospital, Dublin, Ireland.
  • Kelly BO; Department of Genitourinary Medicine and Infectious Diseases, 58024GUIDE Clinic, St James Hospital, Dublin, Ireland.
  • Lynam A; Department of Genitourinary Medicine and Infectious Diseases, 58024GUIDE Clinic, St James Hospital, Dublin, Ireland.
  • Lyons F; Department of Genitourinary Medicine and Infectious Diseases, 58024GUIDE Clinic, St James Hospital, Dublin, Ireland.
  • Devitt E; Department of Genitourinary Medicine and Infectious Diseases, 58024GUIDE Clinic, St James Hospital, Dublin, Ireland.
Int J STD AIDS ; 33(1): 99-102, 2022 01.
Article en En | MEDLINE | ID: mdl-34852685
AIMS: The national PrEP programme launched in Ireland in November 2019 with tenofovir/emtricitabine free to those meeting eligibility criteria. We assessed the impact of the first year of the PrEP programme on new HIV diagnoses in the largest sexual health and HIV service in Ireland. METHODS: A free PrEP service was established in November 2019. We reviewed the number of new diagnoses of HIV between November 2018-2019, before the introduction of the national PrEP programme and compared this with the number of new HIV diagnosis between November 2019-2020. RESULTS: There were 95 new HIV diagnoses (63.3% MSM) between November 2018 and 2019 and 73 new HIV diagnoses (65.7% MSM) between November 2019 and 2020. There was a statistically significant decline in new HIV diagnoses between the 2 years (P = 0.0003). 546 patients were prescribed PrEP as of December 2020.106 patients (19.4%) changed their PrEP dosing regimen due to lockdown. 178 individuals (32.6%) had a rectal infection diagnosed. CONCLUSION: There has been a reduction in new HIV diagnoses in our cohort (although this has occurred during a global pandemic). It is too early to say if PrEP reduces late presentations of HIV based on our findings. A significant number of rectal infections were identified in the PrEP clinic suggesting ongoing risk despite pandemic restrictions. Further research into sexual practices during COVID-19 is needed to assess if this had an impact on the lower rates of HIV acquisition.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición / Minorías Sexuales y de Género / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Int J STD AIDS Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición / Minorías Sexuales y de Género / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Int J STD AIDS Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Reino Unido